Tina Garyantes
Elusys Therapeutics (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Receptor Mechanisms and Signaling, Ocular Oncology and Treatments, Immunotherapy and Immune Responses, Cell Image Analysis Techniques
Most-Cited Works
- → Impact of high-throughput screening in biomedical research(2011)1,328 cited
- → Improving the Reliability and Utility of Streptozotocin-Induced Rat Diabetic Model(2018)161 cited
- Assay Development Guidelines for Image-Based High Content Screening, High Content Analysis and High Content Imaging(2014)
- → Development and Evaluation of High Throughput Functional Assay Methods for hERG Potassium Channel(2001)81 cited
- → Identification of Gap Junction Blockers Using Automated Fluorescence Microscopy Imaging(2003)51 cited
- → The Confirmation Rate of Primary Hits: A Predictive Model(2002)20 cited
- → 1536-well assay plates: when do they make sense?(2002)19 cited
- → The GPER Agonist LNS8801 Induces Mitotic Arrest and Apoptosis in Uveal Melanoma Cells(2023)18 cited
- → Phase 1b study of the novel first-in-class G protein-coupled estrogen receptor (GPER) agonist, LNS8801, in combination with pembrolizumab in patients with immune checkpoint inhibitor (ICI)-relapsed and refractory solid malignancies and dose escalation update.(2022)17 cited
- → Phase 1 trial of a novel, first-in-class G protein-coupled estrogen receptor (GPER) agonist, LNS8801, in patients with advanced or recurrent treatment-refractory solid malignancies.(2021)17 cited